Anxhela Gurakuqi Qirko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anxhela Gurakuqi Qirko has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Albana Gjeli
Department of Internal Medicine, Faculty of Medicine, University of Medicine, Tirana, Albania
1 shared publication Elizana Petrela
Department of Public Health, Biostatistic sector, Faculty of Medicine, University of Medicine, Tirana, Albania
1 shared publication- Eralda Lekli
Department of Internal Medicine, Faculty of Medicine, University of Medicine, 1005 Tirana, Albania
1 shared publication Etleva Qirko Loloci
Department of Internal Medicine, Faculty of Medicine, University of Medicine, Tirana, Albania
1 shared publication- Mehmet Hoxha
Department of Internal Medicine, Faculty of Medicine, University of Medicine, 1005 Tirana, Albania
1 shared publication Nertila Beqo
Department of Internal Medicine, Faculty of Medicine, University of Medicine, Tirana, Albania
1 shared publication
Latest Publications
- Open Access
- 4 January 2023
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 11 (B) , 694-698
Assessment of Medium-Term Impact of Sars-Cov2 Infection on Pulmonary Function in Albanian Young Adults without Previous History of Respiratory Disease
BACKGROUND: No study has been conducted to allow the evaluation of pulmonary dysfunction in Albanian population after medium-severe COVID-19 disease. AIM: We aimed through this project to overview the spirometry data and correlation to other inflammatory markers in post COVID-19 young adults. METHODS: A cross-sectional study was performed to access spirometry as pulmonary function test 3–6 months after COVID-19 in young adults ≤45 years old, hospitalized for COVID-19, and presented no known history for previous pulmonary disease. RESULTS: Among 61 patients, 41 (67.2%) females; mean age 30.6 ± 8.63 years, have undergone a spirometry test 3–6 months after COVID-19. Spirometry data for pulmonary function resulted: 4 patients (6.56%) with pulmonary dysfunction, among them 1 patient (1.64%) Forced expiratory volume in 1 s (FEV1)/Forced vital capacity (FVC) 5), no significant correlation was found regarding FEV1/FVC and FEF 25–75 values among groups. CONCLUSION: The results show that there are few patients that show obstructive pulmonary dysfunction evaluated by spirometry. As investigated by other published studies probably the effects in pulmonary function are improved after few months and bronchial hyper-reactivity post- COVID-19 needs further investigation.
- 4 January 2023
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 11 (B) , 694-698
Open AccessAssessment of Medium-Term Impact of Sars-Cov2 Infection on Pulmonary Function in Albanian Young Adults without Previous History of Respiratory Disease
BACKGROUND: No study has been conducted to allow the evaluation of pulmonary dysfunction in Albanian population after medium-severe COVID-19 disease. AIM: We aimed through this project to overview the spirometry data and correlation to other inflammatory markers in post COVID-19 young adults. METHODS: A cross-sectional study was performed to access spirometry as pulmonary function test 3–6 months after COVID-19 in young adults ≤45 years old, hospitalized for COVID-19, and presented no known history for previous pulmonary disease. RESULTS: Among 61 patients, 41 (67.2%) females; mean age 30.6 ± 8.63 years, have undergone a spirometry test 3–6 months after COVID-19. Spirometry data for pulmonary function resulted: 4 patients (6.56%) with pulmonary dysfunction, among them 1 patient (1.64%) Forced expiratory volume in 1 s (FEV1)/Forced vital capacity (FVC) 5), no significant correlation was found regarding FEV1/FVC and FEF 25–75 values among groups. CONCLUSION: The results show that there are few patients that show obstructive pulmonary dysfunction evaluated by spirometry. As investigated by other published studies probably the effects in pulmonary function are improved after few months and bronchial hyper-reactivity post- COVID-19 needs further investigation.